When VoA Board Member, Rebecca Chopp, was diagnosed in 2019 at age 68 the news was crushing. But there’s good news, too: Because she caught it early, her prognosis is much better than she expected. Chopp’s doing so well, in fact, that she’s written a book called Still Me: Accepting Alzheimer’s Without Losing Yourself.

In the video above, watch as Chopp shares the deeply personal tale of how it felt to become an Alzheimer’s patient and her take on what lies ahead — and below, read a few highlights from the conversation.

Listen to Jim Taylor, President and CEO of Voices of Alzheimer's, to hear his personal journey as a care partner for his wife, Geri, who died of Alzheimer's disease. Jim shares the challenges and triumphs they faced together, as well as the deep emotional bond that sustained them through this journey.

He also speaks to the critical need for community support, the vital role of clinical trials in advancing research, and the power of participation in efforts to find a cure.

Jim Taylor of VoA joined Anne White of Eli Lilly to discuss their shared goal of raising awareness of early detection and accurate diagnosis of Alzheimer's disease.

In this virtual discussion, the Society for Women’s Health Research President & CEO Katie Schubert spoke with Jim Taylor, President of Voices for Alzheimer’s, who brings a unique perspective as both a caregiver and an advocate.

A video by VOA Foundation

VoA board member, Terrie Montgomery, is an individual awardee of the 2024 Maude Awards for her powerful podcast ‘T&L WTD Let’s Talk About It‘, where individuals living with dementia share personal stories, insights, and advocacy efforts.

Voices of Alzheimer's Board Member, Rebecca Chopp never imagined that a routine checkup would lead to the life-changing diagnosis of early-stage Alzheimer’s. While the news was devastating, Rebecca embraced a new chapter—retiring from her role at the University of Denver and focusing on living fully with her loved ones. In Rebecca's case, the benefit of an early-diagnosis allowed her to access effective treatment and change her lifestyle.

Geri Taylor benefitted from now-discontinued Alzheimer's drug for seven years

VoA Champion Dan Jaworski expresses his concerns over the lack of treatment options available for individuals living with the disease

VoA Champion Mike Zuendel addresses frustration with CMS in light of newly approved Alzheimer’s treatments

VoA Board Member Jay Reinstein was interviewed by the Washington Post about accessing Leqembi, a new drug that slows Alzheimer’s disease.

VoA Champion, Dr. Alan Schooley

VoA Champion Michele Hall

VoA Member Bob Toia

VoA Board Member Jay Reinstein protests for Medicare coverage of Alzheimer’s drugs

VoA Board Members Sue Peschin and Jay Reinstein were interviewed by Bloomberg, weighing in on the Medicare coverage of Leqembi

VoA Board Member Philip Gutis wrote an op-ed for the Post-Gazette about recent breakthroughs in Alzheimer’s